Rapt Therapeutics Inc (RAPT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -58,184 | -30,521 | -116,798 | -85,922 | -54,551 |
| Depreciation Amortization | -1,112 | -669 | -4,520 | -3,619 | -2,380 |
| Other Working Capital | -7,892 | -1,876 | 5,499 | 6,489 | 675 |
| Other Operating Activity | 11,950 | 5,982 | 18,771 | 13,758 | 8,846 |
| Operating Cash Flow | $-55,238 | $-27,084 | $-97,048 | $-69,294 | $-47,410 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -34,007 | -16,814 | -161,497 | -106,238 | -73,951 |
| PPE Investments | -104 | -105 | -1,125 | -1,058 | -992 |
| Purchase Of Investment | 69,211 | 32,806 | 266,755 | 190,790 | 132,688 |
| Investing Cash Flow | $35,100 | $15,887 | $104,133 | $83,494 | $57,745 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 9,737 | 9,036 | 1,447 | 989 | 883 |
| Financing Cash Flow | $9,737 | $9,036 | $1,447 | $989 | $883 |
| Beginning Cash Position | 47,478 | 47,478 | 38,946 | 38,946 | 38,946 |
| End Cash Position | 37,077 | 45,317 | 47,478 | 54,135 | 50,164 |
| Net Cash Flow | $-10,401 | $-2,161 | $8,532 | $15,189 | $11,218 |
| Free Cash Flow | |||||
| Operating Cash Flow | -55,238 | -27,084 | -97,048 | -69,294 | -47,410 |
| Capital Expenditure | -104 | -105 | -1,125 | -1,058 | -992 |
| Free Cash Flow | -55,342 | -27,189 | -98,173 | -70,352 | -48,402 |